News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
232,282 Results
Type
Article (5105)
Company Profile (24)
Press Release (227153)
Multimedia
Podcasts (2)
Webinars (4)
Section
Business (82298)
Career Advice (463)
Deals (15061)
Drug Delivery (8)
Drug Development (19079)
Employer Resources (30)
FDA (3690)
Job Trends (3912)
News (120246)
Policy (7514)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (293)
Accelerated approval (6)
Adcomms (4)
Allergies (14)
Alliances (14838)
ALS (38)
Alzheimer's disease (295)
Antibody-drug conjugate (ADC) (40)
Approvals (3789)
Artificial intelligence (96)
Autoimmune disease (27)
Automation (5)
Bankruptcy (97)
Best Places to Work (2869)
Biosimilars (32)
Biotechnology (23)
Bladder cancer (34)
Brain cancer (7)
Breast cancer (102)
Cancer (891)
Cardiovascular disease (62)
Career advice (395)
Career pathing (3)
CAR-T (64)
CDC (2)
Cell therapy (168)
Cervical cancer (5)
Clinical research (16687)
Collaboration (363)
Compensation (371)
Complete response letters (8)
COVID-19 (311)
CRISPR (13)
C-suite (339)
Cystic fibrosis (28)
Data (1332)
Denatured (1)
Depression (21)
Diabetes (78)
Diagnostics (2124)
Digital health (7)
Diversity (1)
Diversity, equity & inclusion (13)
Drug discovery (35)
Drug pricing (14)
Drug shortages (2)
Duchenne muscular dystrophy (35)
Earnings (42752)
Editorial (5)
Employer branding (6)
Employer resources (32)
Events (39165)
Executive appointments (425)
FDA (4432)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (348)
Gene editing (24)
Generative AI (7)
Gene therapy (103)
GLP-1 (144)
Government (423)
Guidances (199)
Healthcare (5052)
HIV (10)
Huntington's disease (5)
IgA nephropathy (11)
Immunology and inflammation (39)
Immuno-oncology (7)
Indications (16)
Infectious disease (337)
Inflammatory bowel disease (36)
Inflation Reduction Act (3)
Influenza (6)
Intellectual property (32)
Interviews (53)
IPO (7883)
IRA (3)
Job creations (1122)
Job search strategy (361)
JPM (5)
Kidney cancer (10)
Labor market (10)
Layoffs (106)
Leadership (5)
Legal (2337)
Liver cancer (21)
Longevity (2)
Lung cancer (92)
Lymphoma (70)
Machine learning (5)
Management (10)
Manufacturing (142)
MASH (50)
Medical device (3931)
Medtech (3941)
Mergers & acquisitions (7587)
Metabolic disorders (216)
Multiple sclerosis (18)
NASH (6)
Neurodegenerative disease (54)
Neuropsychiatric disorders (12)
Neuroscience (541)
NextGen: Class of 2026 (1675)
Non-profit (731)
Now hiring (5)
Obesity (86)
Opinion (33)
Ovarian cancer (26)
Pain (26)
Pancreatic cancer (38)
Parkinson's disease (50)
Partnered (6)
Patents (52)
Patient recruitment (96)
Peanut (6)
People (25231)
Pharmaceutical (7)
Pharmacy benefit managers (2)
Phase 1 (4995)
Phase 2 (7228)
Phase 3 (5789)
Pipeline (1969)
Policy (18)
Postmarket research (625)
Preclinical (1947)
Press Release (66)
Prostate cancer (58)
Psychedelics (3)
Radiopharmaceuticals (110)
Rare diseases (179)
Real estate (1887)
Recruiting (8)
Regulatory (5540)
Reports (17)
Research institute (310)
Resumes & cover letters (69)
Rett syndrome (19)
RNA editing (1)
RSV (2)
Schizophrenia (49)
Series A (54)
Series B (56)
Sickle cell disease (10)
Special edition (1)
Spinal muscular atrophy (33)
Sponsored (5)
Startups (1022)
Stomach cancer (1)
Supply chain (14)
Tariffs (7)
The Weekly (1)
Vaccines (80)
Venture capital (10)
Weight loss (30)
Women's health (7)
Date
Last 7 days (147)
Last 30 days (573)
Last 365 days (8944)
2026 (794)
2025 (9091)
2024 (11077)
2023 (13225)
2022 (18678)
2021 (19696)
2020 (18262)
2019 (13237)
2018 (10222)
2017 (10011)
2016 (9157)
2015 (12119)
2014 (9588)
2013 (7710)
2012 (8332)
2011 (8797)
2010 (8636)
Location
Africa (186)
Alabama (19)
Alaska (2)
Arizona (74)
Arkansas (1)
Asia (11819)
Australia (1690)
California (3567)
Canada (1138)
China (169)
Colorado (143)
Connecticut (165)
Delaware (70)
Europe (25526)
Florida (541)
Georgia (67)
Idaho (24)
Illinois (162)
India (14)
Indiana (108)
Iowa (9)
Japan (164)
Kansas (36)
Kentucky (17)
Louisiana (8)
Maine (51)
Maryland (354)
Massachusetts (2827)
Michigan (104)
Minnesota (201)
Mississippi (1)
Missouri (32)
Montana (17)
Nebraska (12)
Nevada (46)
New Hampshire (16)
New Jersey (1018)
New Mexico (5)
New York (820)
North Carolina (480)
North Dakota (4)
Northern California (1867)
Ohio (116)
Oklahoma (5)
Oregon (6)
Pennsylvania (597)
Puerto Rico (1)
Rhode Island (19)
South America (279)
South Carolina (17)
Southern California (1314)
Tennessee (61)
Texas (492)
United States (12402)
Utah (111)
Virginia (84)
Washington D.C. (17)
Washington State (298)
West Virginia (2)
Wisconsin (57)
Wyoming (1)
232,282 Results for "nvidia corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
LexBio Named One of Ten “Honored Enterprises” in NVIDIA Inception Showcase 2025
The recognition underscores LexBio’s leadership in applying large-scale AI and advanced computing to next-generation drug discovery
January 19, 2026
·
1 min read
Press Releases
Freenome Announces Expanded Artificial Intelligence and Deep Learning Initiatives Accelerated by NVIDIA, to Advance Personalized Multi-Cancer Detection
January 13, 2026
·
4 min read
Artificial intelligence
J&J, Lilly Crest AI Wave With Nvidia Partnerships
Eli Lilly and Johnson & Johnson are joining fellow Big Pharma peers in upping their investment in AI, with Lilly looking to create the industry’s ‘most powerful supercomputer’ and J&J building a virtual operating room.
October 29, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Greenstone Biosciences Advances AI-Driven Human Models for Drug Safety and Efficacy with NVIDIA
October 29, 2025
·
1 min read
Press Releases
Hoth Therapeutics Expands Artificial Intelligence Initiative, Selects NVIDIA AI Enterprise Platform
October 9, 2025
·
5 min read
Press Releases
Lilly partners with NVIDIA to build the industry’s most powerful AI supercomputer, supercharging medicine discovery and delivery for patients
October 28, 2025
·
6 min read
Press Releases
NVIDIA Partners With Novo Nordisk and DCAI to Advance Drug Discovery
June 11, 2025
·
6 min read
Press Releases
Stereotaxis Highlighted by NVIDIA at GTC Artificial Intelligence Conference and Accepted into NVIDIA Connect Program
March 19, 2025
·
3 min read
Lone Star Bio
Monogram Accepted to NVIDIA Inception Program
Monogram Orthopaedics Inc. today announced it has joined NVIDIA Inception, a program designed to help companies evolve faster through cutting-edge technology and access to the latest technical resources from NVIDIA.
April 11, 2024
·
4 min read
Press Releases
IonQ Speeds Quantum-Accelerated Drug Development Application With AstraZeneca, AWS, and NVIDIA
June 9, 2025
·
7 min read
1 of 23,229
Next
